JSPR
Jasper Therapeutics Inc
0.6091$
+4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | +118.1% | -100.0% | – | – | |
| – | – | +2,595.2% | +131.4% | -15.4% | +23.9% | -23.1% | |
| – | – | – | – | – | – | – | |
| – | +339.0% | +60.1% | +36.2% | +49.6% | +7.8% | +8.4% | |
| – | +339.6% | +137.8% | +45.2% | +3.1% | +19.6% | -7.2% | |
| – | +339.1% | +78.1% | +39.0% | +34.5% | +10.7% | +4.2% | |
| – | – | – | – | – | – | – | |
| – | – | -43.6% | +118.1% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.